{"title":"白化小鼠诱导乳腺癌疫苗对免疫系统刺激的评价","authors":"Ruaa Sh, S. Mohammed, Hamid Naji","doi":"10.48141/sbjchem.v29.n30.2021.05_mohammed_pgs_44_52.pdf","DOIUrl":null,"url":null,"abstract":"This study was designed to prepare vaccines. Cancer vaccines promote the destruction of cancer cells,and the cancer cells contain special antigens on their surface when the vaccine is given, it acts as an antigen to activate the immune system. The IL-2 stimulates the response to a type of cells called T-cell, and outer membrane vesicle (OMV) targeting cancer cells by stimulating the immunity to respond with it two types including innate and adaptive immunity, that lead to stimulating the immune system to reduce mammary adenocarcinoma induction in lab mice using T4-1 cell line breast cancer by taking blood and serum to evaluate the immune system efficacy. The tumor induction success by monitoring mice body weight loss showed the lost weight began in the third week after tumor induction, so 23.2 g at first and second week to 14.35 g at the end of the fourth week, whereas the control animals were weighed 32.37 g. The immunity system efficacy results appear a difference in blood and serum parameters after cancer induction. The result shows an increase in total WBC and monocytes (5900, 0.2 cells/mm respectively) but non significantly decreased in neutrophils and lymphocytes count (2.6, 5.9 cells/mm, respectively). Therefore, the first and second doses of vaccines increased the antibody and complement of the immune system compared with control. While Eliaza data for cytokines profile referred to elevated IL2 (26.5 pg/ml)in the serum of vaccination mice but only significantly decreased in IL6 and IL-22 amount (20.4 and 19.6 pg/ml respectively) comparing with control.","PeriodicalId":20606,"journal":{"name":"Proceedings of the SOUTHERN BRAZILIAN JOURNAL OF CHEMISTRY 2021 INTERNATIONAL VIRTUAL CONFERENCE","volume":"13 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"EVALUATION OF IMMUNE SYSTEM STIMULATION WITH VACCINE PREPARED AGAINST INDUCED BREAST CANCER IN ALBINO MICE\",\"authors\":\"Ruaa Sh, S. Mohammed, Hamid Naji\",\"doi\":\"10.48141/sbjchem.v29.n30.2021.05_mohammed_pgs_44_52.pdf\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This study was designed to prepare vaccines. Cancer vaccines promote the destruction of cancer cells,and the cancer cells contain special antigens on their surface when the vaccine is given, it acts as an antigen to activate the immune system. The IL-2 stimulates the response to a type of cells called T-cell, and outer membrane vesicle (OMV) targeting cancer cells by stimulating the immunity to respond with it two types including innate and adaptive immunity, that lead to stimulating the immune system to reduce mammary adenocarcinoma induction in lab mice using T4-1 cell line breast cancer by taking blood and serum to evaluate the immune system efficacy. The tumor induction success by monitoring mice body weight loss showed the lost weight began in the third week after tumor induction, so 23.2 g at first and second week to 14.35 g at the end of the fourth week, whereas the control animals were weighed 32.37 g. The immunity system efficacy results appear a difference in blood and serum parameters after cancer induction. The result shows an increase in total WBC and monocytes (5900, 0.2 cells/mm respectively) but non significantly decreased in neutrophils and lymphocytes count (2.6, 5.9 cells/mm, respectively). Therefore, the first and second doses of vaccines increased the antibody and complement of the immune system compared with control. While Eliaza data for cytokines profile referred to elevated IL2 (26.5 pg/ml)in the serum of vaccination mice but only significantly decreased in IL6 and IL-22 amount (20.4 and 19.6 pg/ml respectively) comparing with control.\",\"PeriodicalId\":20606,\"journal\":{\"name\":\"Proceedings of the SOUTHERN BRAZILIAN JOURNAL OF CHEMISTRY 2021 INTERNATIONAL VIRTUAL CONFERENCE\",\"volume\":\"13 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of the SOUTHERN BRAZILIAN JOURNAL OF CHEMISTRY 2021 INTERNATIONAL VIRTUAL CONFERENCE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.48141/sbjchem.v29.n30.2021.05_mohammed_pgs_44_52.pdf\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the SOUTHERN BRAZILIAN JOURNAL OF CHEMISTRY 2021 INTERNATIONAL VIRTUAL CONFERENCE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48141/sbjchem.v29.n30.2021.05_mohammed_pgs_44_52.pdf","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
EVALUATION OF IMMUNE SYSTEM STIMULATION WITH VACCINE PREPARED AGAINST INDUCED BREAST CANCER IN ALBINO MICE
This study was designed to prepare vaccines. Cancer vaccines promote the destruction of cancer cells,and the cancer cells contain special antigens on their surface when the vaccine is given, it acts as an antigen to activate the immune system. The IL-2 stimulates the response to a type of cells called T-cell, and outer membrane vesicle (OMV) targeting cancer cells by stimulating the immunity to respond with it two types including innate and adaptive immunity, that lead to stimulating the immune system to reduce mammary adenocarcinoma induction in lab mice using T4-1 cell line breast cancer by taking blood and serum to evaluate the immune system efficacy. The tumor induction success by monitoring mice body weight loss showed the lost weight began in the third week after tumor induction, so 23.2 g at first and second week to 14.35 g at the end of the fourth week, whereas the control animals were weighed 32.37 g. The immunity system efficacy results appear a difference in blood and serum parameters after cancer induction. The result shows an increase in total WBC and monocytes (5900, 0.2 cells/mm respectively) but non significantly decreased in neutrophils and lymphocytes count (2.6, 5.9 cells/mm, respectively). Therefore, the first and second doses of vaccines increased the antibody and complement of the immune system compared with control. While Eliaza data for cytokines profile referred to elevated IL2 (26.5 pg/ml)in the serum of vaccination mice but only significantly decreased in IL6 and IL-22 amount (20.4 and 19.6 pg/ml respectively) comparing with control.